Biosense Webster Announces FDA Submission for Approval of the Varipulse Platform
All 20 participants in a 12-month follow-up study attained acute success from ablation procedures.
Biosense Webster Johnson Medtech Biosense Webster Inc Varipulse Platform Varipulse Catheter Trupulse Generator
Source: pharmacytimes.com